Gossamer Bio Stock (NASDAQ: GOSS) stock price, news, charts, stock research, profile.
Open | $0.90 |
Close | $0.91 |
Volume / Avg. | 477.45K / 2.06M |
Day Range | $0.87 - $0.93 |
52 Wk Range | 0.45 - 1.60 |
Market Cap | $210.17M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 51 |
Short Interest | 4.38% |
Days to Cover | 7.03 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Gossamer Bio (NASDAQ:GOSS) through any online brokerage.
Other companies in Gossamer Bio’s space includes: Molecular Partners (NASDAQ:MOLN), Macrogenics (NASDAQ:MGNX), Outlook Therapeutics (NASDAQ:OTLK), Innate Pharma (NASDAQ:IPHA) and Zentalis Pharma (NASDAQ:ZNTL).
Gossamer Bio has a consensus price target of $7.96.
The stock price for Gossamer Bio (NASDAQ: GOSS) is $0.929 last updated August 23, 2024 at 6:31 AM EDT.
There are no upcoming dividends for Gossamer Bio.
Gossamer Bio’s Q3 earnings are confirmed for Thursday, November 7, 2024.
There is no upcoming split for Gossamer Bio.
Gossamer Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.